Full Text View
Tabular View
Study Results
Related Studies
Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)
This study has been completed.
Study NCT00779116   Information provided by Merck Sharp & Dohme Corp.

First Received on October 23, 2008.   Last Updated on April 6, 2015   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial